Transforming Renal Care through Patient-Centric Innovations.
Baxter has been a front-runner in the treatment and management of end-stage kidney disease for over 85 years. Today, our state-of-the-art solutions for both haemodialysis and peritoneal dialysis are transforming global renal care. It’s why you can rely on us to be the type of dedicated partner who understands the challenges you face throughout the continuum of care to meet the individual needs of your patients.
Explore our Therapies
PD
PD THERAPY
Peritoneal Dialysis - combined with Remote Patient Management - offers end-stage kidney disease patients the potential to improve clinical outcomes and increase lifestyle flexibility.
HD
HD THERAPY
Haemodialysis is the predominant therapy for end-stage kidney disease patients, and can be delivered through multiple therapy options.
HDx
HDx THERAPY
Innovative Expanded Haemodialysis (HDx) therapy is the next evolution in haemodialysis treatment.